Join Avance Clinical at the 17th Annual Outsourcing in Clinical Trials New England 2025
Avance Clinical will be attending the 17th Annual Outsourcing in Clinical Trials New England 2025.
Search results
We found 37 results for: “preclinical”
Avance Clinical Clinical Leader Solutions Expo May 2025: CRO Services – Oncology
This presentation outlines the key success factors driving high-impact oncology drug development, with a focus on translating innovative science into clinically and commercially meaningful outcomes.
Strategic Partnership Between Avance Clinical and Kaohsiung Medical University Chung-Ho Memorial Hospital- Strengthens Asia’s Clinical Trial Network
Avance Clinical has signed a Memorandum of Understanding (MOU) with Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH), a top-tier clinical research hospital in Taiwan, recognized for its excellence in conducting high-quality clinical trials and its leadership in medical innovation.
Avance Clinical Signs Memorandum of Understanding with Taichung Veterans General Hospital, Expanding Trial Site Network in Taiwan
Avance Clinical signed a Memorandum of Understanding (MOU) with Taichung Veterans General Hospital (TCVGH), one of Taiwan’s leading medical centers with extensive clinical trial expertise.
Avance Clinical and Taipei Medical University Join Forces to Accelerate Clinical Research and Biotech Innovation in Asia
Avance Clinical as signed a Memorandum of Understanding (MOU) with Taipei Medical University (TMU), one of Taiwan’s leading medical institutions with extensive clinical trial expertise.
Avance Clinical to attend BIO Europe Spring in Milan, Italy
Avance Clinical excited to announce its participation in BIO-Europe Spring 2025, taking place from March 17–19 in Milan, Italy.
Ensure Seamless Clinical Trial Transition Across Global Markets
For early-stage biotech companies, securing funding is often a significant challenge due to the complex and costly nature of drug development.
Delivering High-Quality Trials With Expert Consultation And Management In Cancer Research
For early-stage biotech companies, securing funding is often a significant challenge due to the complex and costly nature of drug development.
Demystifying Cell and Gene Therapy Studies in Australia and the Broader APAC Region
For early-stage biotech companies, securing funding is often a significant challenge due to the complex and costly nature of drug development.
How Avance Clinical’s In-house ClinicReady Service Supports Early-Stage Biotech Companies to Secure Funding
For early-stage biotech companies, securing funding is often a significant challenge due to the complex and costly nature of drug development.